Actively Recruiting
Acute Myocarditis Registry With Prognostic, Histologic, Immunologic, Biological, Imaging and Clinical Assessment
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-06-06
1400
Participants Needed
1
Research Sites
1005 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The AMPHIBIA study is an observational ambispective and prospective cohort that aim to describe the histologic, immunologic, biological, imaging, genetic and clinical characteristics of the patients hospitalized for an acute myocarditis and to evaluate their association with prognosis.
CONDITIONS
Official Title
Acute Myocarditis Registry With Prognostic, Histologic, Immunologic, Biological, Imaging and Clinical Assessment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Acute myocarditis confirmed by cardiac magnetic resonance according to Lake Louise modified criteria or by endomyocardial biopsy according to histologic, immunologic and immunohistochemic criteria.
- Affiliation to the French Health Care System "S�e9curit�e9 sociale"
You will not qualify if you...
- Severe valvulopathy
- Complex congenital cardiopathy
- Previous heart transplant
- Known significative coronary disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hôpital Pitié-Salpêtrière
Paris, France, 75013
Actively Recruiting
Research Team
M
Mathieu Kerneis, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here